Skip to main content
. 2018 Aug 2;2:PO.18.00101. doi: 10.1200/PO.18.00101

Fig 4.

Fig 4.

Timeline. IE, ifosfamide and etoposide; NGS, next-generation sequencing; NRSTS, nonrhabdomyosarcoma soft tissue sarcoma; PET, positron emission tomography; RECIST, Response Evaluation Criteria in Solid Tumors; VAdriaC, vincristine, doxorubicin, and cyclophosphamide.